A practical reference on research chemical: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2025-09-25. Anything still debated is marked as such rather than presented as settled.
SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.
Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.
Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.
Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.
Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.
Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved as a medicine in major jurisdictions | Sold as a research chemical; legal status varies |
| Anti-doping status | Prohibited by the World Anti-Doping Agency | Listed under non-approved substances or related category |
| Typical analytical method | LC-MS/MS | Used for detection and confirmation in biological samples |
| Storage temperature | −20 °C or lower for solid | Desiccated and protected from light |
| Common solution solvents | DMSO; ethanol | Aqueous solubility is limited |
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
The mechanism of action involves binding to REV-ERB receptors and recruiting corepressor complexes, which represses target gene transcription. This contrasts with many nuclear receptor agonists that activate transcription. Downstream effects may include changes in autophagy, mitochondrial biogenesis, and lipid handling, but the precise pathways remain an active area of study. Whether these molecular events translate into meaningful physiological effects in humans is unresolved. Most evidence comes from cultured cells and rodent models rather than human participants.
SR9009 is a synthetic small molecule developed as an agonist of the nuclear receptors REV-ERBα (NR1D1) and REV-ERBβ (NR1D2). These receptors help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, SR9009 alters transcription of genes involved in lipid metabolism, inflammation, and mitochondrial function. It is not an approved medicine, and its pharmacological profile in humans remains largely uncharacterized. The compound is frequently discussed in the context of circadian biology and metabolic research rather than clinical use.
Preclinical reports have linked SR9009 to improved endurance and altered energy expenditure in rodents. Such findings have prompted interest in whether REV-ERB activation can influence skeletal muscle metabolism. However, the reported effects depend on dose, route, and experimental model, and replication across laboratories is limited. Human trials have not established comparable outcomes, so claims about exercise performance remain speculative. The absence of controlled human data is a central limitation in interpreting these observations.
== Flexible design == The functional group, the spacer and the lipid tail components of the FSL Kode construct can each be individually designed resulting in FSL Kode constructs with specific biological functions. The functional head group is usually the bioactive component of the construct and the various spacers and lipids influence and effect its presentation, orientation and location on a surface. Critical to the definition of an FSL Kode construct is the requirement to be dispersible in water, and spontaneously and stably incorporate into cell membranes. Other lipid bioconjugates that include components similar to FSLs but do not have these features are not termed as Function-Spacer-Lipid Kode constructs.
== History == Generate:Biomedicines was founded in 2018 by Flagship Pioneering. The company was established to develop a data-driven approach to understanding the relationship between protein sequence and function with the aim of creating novel proteins for therapeutic purposes. The company operated in stealth mode until its public unveiling on September 10, 2020. At that time, Generate announced its focus on using machine learning algorithms and big data to design biological compounds targeting multiple diseases, including SARS-CoV-2, the virus causing COVID-19. Its computational platform integrated vast datasets of protein structures and genetic sequences to develop governing rules for designing new proteins. In March 2021, Mike Nally, formerly of Merck, joined as chief executive officer to advance the company's technology and operational capabilities. Under his leadership, Generate expanded its infrastructure and initiated multiple strategic collaborations. By 2023, Generate had raised financing, including a $273 million Series C round, the largest biotech Series C of the year. These funds supported the company's first-in-human clinical trial for GB-0669, a monoclonal antibody targeting a conserved region of the SARS-CoV-2 spike protein, and its pipeline of 17 programs spanning immunology, infectious disease, and oncology. In September 2024, Generate secured a partnership with Novartis, potentially worth over $1 billion, to leverage its generative artificial intelligence (AI) platform for the development of protein therapeutics.
Modafinil was added to the list of prohibited substances on 3 August 2004, ten days before the start of the 2004 Summer Olympics. One approach of athletes to get around regulations on stimulants is to use new designer stimulants, which have not previously been officially prohibited, but have similar chemical structures or biological effects. Designer stimulants that attracted media attention in 2010 included mephedrone, ephedrone, and fluoroamphetamines, which have chemical structures and effects similar to ephedrine and amphetamine.
Sources: en.wikipedia.org
=== Bi–Bo === Klaus Biemann (1926–2016). Austrian chemist at MIT, the "father of organic mass spectrometry" and particularly noted for his role in advancing protein sequencing with tandem mass spectrometry. Member Natl. Acad. Sci. USA. Ethel Ronzoni Bishop (1890–1975). American biochemist and physiologist at Washington University in St. Louis who studied carbohydrate metabolism. Pamela J. Bjorkman (b. 1956). American biochemist at Caltech, who studies immune recognition of viral pathogens. Member Natl. Acad. Sci. USA. Elizabeth Blackburn AC FRS FAA FRSN (b. 1948). Australian-American biochemist, Nobel Laureate, co-discoverer of telomerase. Konrad Emil Bloch FRS (1912–2000). German-American biochemist at Harvard, who worked on the mechanism and regulation of cholesterol and fatty acid metabolism. Nobel Prize in Physiology or Medicine 1964. Elkan Blout (1919–2006). American biochemist at Harvard, who worked on peptide structure and conformation, including cyclic peptides. Member Natl. Acad. Sci. USA. David Mervyn Blow FRS (1931–2004). British X-ray crystallographer at Imperial College London, who worked on protein structure. Tom Blundell, FRS (b. 1942). British biochemist at the University of Cambridge, structural biologist, and science administrator. Aaron Bodansky (1887–1960). Russian-born American biochemist at the Hospital for Joint Diseases, New York, specializing in the area of calcium metabolism. Paul D. Boyer (1918–2018). American biochemist, at UCLA who studied ATP synthase. Nobel Prize in Chemistry in 1997. Member Natl. Acad. Sci. USA.
Sydney Harbour A unit of volume used in Australia for water. One Sydney Harbour is the amount of water in Sydney Harbour: approximately 562 gigalitres (562,000,000 cubic metres, or 0.562 cubic kilometres); or in terms of the more unusual measures above, about 357 Melbourne Cricket Grounds, 238,000 Olympic Swimming pools, or 476,000 acre-feet. The Grand Canyon With a volume measure approximately 4 orders of magnitude greater than Sydney Harbour, the volume of the Grand Canyon may be used to visualize even larger things, like the magma chamber underneath Yellowstone and other things. According to the National Park Service, the volume of the Grand Canyon is 4.17 trillion cubic metres (5.45 trillion cubic yards) which is 4,170 km3 (1,000 mi3).
==== Anorexia as adaptation ==== Studies have hypothesized that disordered eating patterns may also arise secondary to starvation. The results of the Minnesota Starvation Experiment, for example, showed that normal controls will exhibit many of the same behavioral patterns associated with AN when subjected to starvation. Similarly, scientific experiments conducted using mice have suggested that other mammals exhibit these same behaviors, especially compulsive movement, when caloric restriction is induced, likely mediated by various changes in the neuroendocrine system. This has given further rise to the hypothesis that anorexia nervosa and other restrictive eating disorders may be an evolutionarily advantageous adaptive response to a perceived famine in the environment. Recent research has further expanded this perspective, showing how caloric restriction may be adaptive in volatile or uncertain environment - thus potentially explaining the association between an increased risk to develop anorexia nervosa and adverse childhood experiences.
==== 19 April ==== President Trump announced that the US had attacked the Iran-flagged cargo ship Touska after it attempted to breach the US naval blockade of Iran, blowing a hole in its engine room and taking the ship into custody. The vessel, almost 900 feet (270 m) long, was en route to Bandar Abbas. It was warned by the USS Spruance over a six-hour period before the destroyer fired several rounds from its 5-inch/54-caliber Mark 45 gun into the engine room, disabling it. It was then seized by the 31st Marine Expeditionary Unit in the Gulf of Oman. Iran described the seizure as a truce violation.
Sources: en.wikipedia.org
=== Phase 2 === AGX-201 (histamine dihydrochloride salt) – histamine H1 receptor antagonist and histamine H3 receptor agonist – migraine [7] BHV-2100 – transient receptor potential cation channel subfamily M member 3 (TRPM3) antagonist – migraine [8] Botulinum toxin A longer acting (IPN-10200; mrBoNT) – acetylcholine release inhibitor and neuromuscular blocking agent – migraine [9] CAM-01 (C-AM-01) – undefined mechanism of action – migraine [10] Dihydroergotamine mesilate (DFN-19) – non-selective monoamine receptor modulator and ergoline – migraine [11] Doxepin intranasal (Dolorac) – tricyclic antidepressant (non-selective monoamine reuptake inhibitor and receptor modulator and other actions) – headache [12] Elismetrep (K-304; MT-8554) – transient receptor potential cation channel subfamily M member 8 (TRPM8) antagonist – migraine [13] Erenumab (Aimovig; AMG-334) – monoclonal antibody against calcitonin gene-related peptide receptor (CGRPR) – headache [14] Eslicarbazepine acetate (Aptiom; BIA 2-093; ESL; Exalief; SEP-0002093; SEP-2093; Stedesa; Zebinix) – sodium channel blocker – migraine [15] IONIS-PKKRx (ISIS-546254; ISIS-PKKRx) – antisense oligonucleotide against kallikrein – migraine [16] Ketoprofen topical (ELS-M11; Topofen) – COX inhibitor/NSAID – migraine [17] LAT-8881 (AOD9604; Tyr-hGH171191) – human growth hormone protein fragment and lanthionine synthetase C-like protein (LanCL) ligand – migraine [18] LU-AG09222 (ALD-1910) – monoclonal antibody against pituitary adenylate cyclase-activating polypeptide (PACAP) – migraine [19] LY-3451838 (PACAP-38 antibody) – monoclonal antibody against pituitary adenylate cyclase-activating polypeptide (PACAP) – migraine [20] Lysergic acid diethylamide (LSD; MM-120) – non-selective serotonin receptor agonist and psychedelic hallucinogen – cluster headache [21] MTX-101 – undefined mechanism of action – migraine [22] Pasireotide (Signifor; SOM-230) – somatostatin receptor agonist – cluster headache [23] Prabotulinumtoxin A (ABP-450; DWP-450; Evosyal; Jeuveau; Nabota; Nuceiva) – acetylcholine release inhibitor and neuromuscular blocking agent – migraine [24] Sepranolone (isoallopregnanolone; UC-1010) – GABAA receptor negative allosteric modulator and neurosteroid – menstrual migraine [25] TRV-250 – δ-opioid receptor (DOR) agonist – migraine [26] (R)-Verapamil – calcium channel blocker and other actions – cluster headache [27] Zelminemab (AMG-301) – monoclonal antibody against pituitary adenylate cyclase-activating polypeptide type I receptor (PAC1R) – migraine [28]
A smaller Bektashi tekke, the Dikmen Baba Tekkesi, is in operation in the Turkish-speaking town of Kanatlarci, North Macedonia that also has stronger ties with Turkish Bektashis. In Kosovo, the relatively small Bektashi community has a tekke in the town of Gjakovë and was under the leadership of Baba Mumin Lama until his passing in 2021. This community recognizes the Bektashi leadership of Tirana. In Bulgaria, the türbes of Kıdlemi Baba, Ak Yazılı Baba, Demir Baba, and Otman Baba function as heterodox Islamic pilgrimage sites, and before 1842 were the centers of Bektashi tekkes. Bektashis continue to be active in Turkey and their semi-clandestine organizations can be found in Istanbul, Ankara and İzmir. The community in Turkey was headed by Debebaba Bedri Noyan from 1960 until his death in 1997. There are currently two rival claimants to the Dedebabate in Turkey: Mustafa Eke and Haydar Ercan. A large, functioning Bektashi tekke was established in the United States in 1954 by Baba Rexheb in the Detroit suburb of Taylor, and the tomb (türbe) of Baba Rexheb continues to draw pilgrims of all faiths.
The Russification policies were harsh, and there were many repressions, particularly in the aftermath of the November Uprising (1830–1831) and later, the January Uprising of 1863–1864. Many Poles were exiled to Siberia, some 80,000 of them in 1864 in the single largest deportation action commenced by the empire. Polish language was discriminated against, and it lost its official status. "Books were burned; churches destroyed; priests murdered;" wrote Norman Davies. There was no education in the Polish language, and publications in Polish were few. The only elementary schools were constantly underfinanced. The city of Warsaw under the Tsarist rule resembled a military base with exclusively Russian stores and clubs as well as 12 Russian garrisons in the city, equipped with newly built horse stables, and amenities like laundry shacks, and cabbage pickleries. Polish stores – where Russian was not being spoken – were routinely denied a license. Polish names were removed even from botanical signs. Hunger and poverty were rampant with record number of women forced to work at the Russian military brothels, of which there were some 185 in total, including 16 official ones (1884). In cheap army brothels, sex could be bought for as little as 30 kopecks (less than 1/3 of a rouble); one woman for every 30 Russians stationed at a garrison, with beatings and instances of women getting killed by them in drunken rages. Sex slaves were obliged to drink with the clients as a general rule.
The goal of this process is to reduce the amount of material being transferred to the surface and minimize land-based. The dewatering process is a mining waste process that would most likely contribute to the formation of sediment plumes from the surface. The method of mine waste disposal releases water from the ship that may have been obtained during the extraction and transport of the material from the seafloor to the surface. The third contribution to the formation of the sediment plume or cloud would be sediment disturbance and release. This mining waste contribution is mainly associated with the mining activity on the seafloor associated with the movement of the ROVs and the destructive disturbance of the seafloor as part of the mining process itself. The two main environmental concerns as a result of these waste mining processes that contribute to the formation of the sediment plume would be the release of heavy metals and increased amounts of sediment released. The release of heavy metals is mainly associated with the dewatering process that would take place on board the ship at the surface of the water. The main problem associated with dewatering is that it is not just the release of seawater re-entering the water column. Heavy metals such as copper and cobalt that would be sourced from the material extracted on the seafloor are also mixed in with the water that is released into the water column. The first environmental concern associated with the release of heavy metals is that it has the potential to change ocean chemistry within that localized water column area.
This is important because polysaccharide vaccines elicit antibody responses without T cell help, and as a result, those antibody responses tend to be weak and short-lived (and young children have a particularly difficult time generating these antibodies for developmental reasons, which is a major issue because the polysaccharides in question are present on the surfaces of pathogenic bacteria). However, attaching the polysaccharide to a carrier protein (especially an immunogenic one, such as tetanus toxoid) enables B cells that recognize the polysaccharide to get help from T cells that recognize the carrier protein's peptides. These are known as conjugate vaccines or glycoconjugates. Moreover, the processing of an antigen by an antigen-presenting cell causes loss of the tertiary structure of the protein, meaning that T cells recognize linear epitopes only (the amino acids recognized have to be next to each other in the primary structure). There are also subsets of T cells known as unconventional T cells that may recognize non-peptide antigens, or peptides. Many of these subsets show predominantly innate, rather than adaptive, functions.
Sources: en.wikipedia.org
Its legal status depends on the country and intended use. It is not an approved medicine in major jurisdictions. In sport, it is prohibited by anti-doping rules.
Laboratories typically use LC-MS/MS to detect SR9009 and related compounds in urine or blood. The method is sensitive but depends on sample collection timing. Confirmatory analysis follows quality-control procedures.
Solid material is generally kept cold, dry, and protected from light. Solutions are often stored in sealed containers at low temperature. Stability beyond recommended periods is not well documented.
The most common approach is liquid chromatography-tandem mass spectrometry, often after extraction from blood, urine, or tissue. Ultraviolet detection and nuclear magnetic resonance spectroscopy are used mainly for reference material characterization. Isotope-labeled internal standards improve accuracy.